Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call

About this update from Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p.prnews_p { font-size:0.62em; font-family:"Arial"; color:black; margin:0in; } .prngen2{ PADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt } .prnml4{ MARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT } .prnbcc{ BORDER-COLLAPSE: COLLAPSE } Canada NewsWire MISSISSAUGA, ON , May 3, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release its financial results for the first quarter of 2024 after the market close on Thursday, May 9, 2024 . The Company will also hold a conference call on Friday, May 10, 2024 at 8:30 ET to discuss the results and corporate developments. CONFERENCE CALL DETAILS DATE: May 10, 2024 TIME: 8:30AM DIAL-IN NUMBER: 416-764-8650 or 888-664-6383 REPLAY: 416-764-8677 or 888-390-0541 Code:196164# Expires: May 17, 2024 WEBCAST: https://app.webinar.net/ZQPqmBaVGEn About Cipher Pharmaceuticals Inc. Cipher Pharmaceuticals (TSX:CPH) (OTCQX:CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com . SOURCE Cipher Pharmaceuticals Inc. View original content: http://www.newswire.ca/en/releases/archive/May2024/03/c9197.html

View stock analysis, news, and events for Cipher Pharmaceuticals Inc.